Kwality Pharmaceuticals
add_icon

Kwality Pharmaceuticals

3,343.00
+29.20
(0.88%)
Market Cap
3,468.76 Cr
PE Ratio
42.49
Volume
30,682.00
Day High - Low
3,398.00 - 3,220.00
52W High-Low
3,450.00 - 1,561.00
hide
Key Fundamentals
Add Ratio
split_icon_default
Market Cap
3,468.76 Cr
EPS
64.90
PE Ratio
42.49
PB Ratio
10.41
Book Value
318.80
EBITDA
121.10
Dividend Yield
0.00 %
Industry
Healthcare
Return on Equity
20.41
Debt to Equity
0.41
Forecast For
Actual

Company News

View All News
Caret
neutral
Kwality Pharmaceuticals held a virtual knowledge session for investors on August 10, 2026. Management discussed business operations and outlook using only public information.
positive
Kwality Pharmaceuticals Ltd reported a 69% YoY jump in PAT to ₹67.3 crore for FY26, driven by 36% revenue growth to ₹503 crore and margin expansion.
neutral
Kwality Pharmaceuticals Ltd held its board meeting on August 8, 2026, approving the FY26 annual report and scheduling the 43rd AGM for August 31. Key decisions include reappointing Aditya Arora as WTD and regularizing Swanith Kapoor as Independent Director.
View more
Competitors
LTP
Market Cap (₹ Cr.)
P/E Ratio
Revenue (₹ Cr.)
YoY Revenue Growth %
Net Profit (₹ Cr.)
YoY Profit Growth %
RSI
1,932.00
#1 4,63,551.52
38.32
#1 61,673.90
12.69
#1 11,565
26.53
47.73
8,500.00
2,25,648.29
77.55
11,067.00
13.95
2,568
65.50
72.97
4,914.50
1,86,931.78
86.27
13,886.20
20.34
2,138
3.28
51.09
1,458.80
1,17,848.47
35.18
29,044.60
2.24
3,870
-39.18
54.09
1,167.30
1,17,457.69
26.15
27,657.90
17.64
5,026
-34.90
58.57
2,250.30
1,02,891.04
#1 18.65
29,038.90
#1 26.75
5,356
16.00
31.41
1,206.00
1,00,661.09
31.44
35,058.60
3.90
4,158
-69.10
50.92
1,851.70
99,965.24
91.23
6,867.80
22.01
890
#1 123.93
77.76
2,404.40
99,300.75
48.43
14,636.40
14.85
1,938
29.13
40.22
1,663.40
95,708.36
26.06
34,145.20
5.56
3,503
25.21
64.66
Growth Rate
Revenue Growth
35.96 %
Net Income Growth
69.10 %
Cash Flow Change
-67.64 %
ROE
34.54 %
ROCE
18.87 %
EBITDA Margin (Avg.)
8.23 %

Quarterly Financial Results

Quarterly Financials
Jun 2021
Sept 2021
Dec 2021
Mar 2022
Jun 2022
Sept 2022
Dec 2022
Mar 2023
Jun 2023
Sept 2023
Dec 2023
Mar 2024
Jun 2024
Sept 2024
Dec 2024
Mar 2025
Jun 2025
Sept 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
121
184
89
66
71
57
57
70
68
70
79
93
80
90
85
117
112
112
124
158
163
Expenses
73
100
64
48
52
40
41
74
54
54
61
78
63
70
67
90
87
86
94
118
121
EBITDA
49
84
25
18
18
17
16
-4
14
16
17
14
18
20
18
27
25
26
30
40
42
Operating Profit %
40 %
45 %
28 %
25 %
26 %
28 %
27 %
-7 %
20 %
22 %
21 %
15 %
22 %
22 %
21 %
22 %
22 %
23 %
24 %
25 %
25 %
Depreciation
2
3
3
3
3
4
4
4
5
5
5
5
4
5
5
5
5
5
5
5
5
Interest
1
1
1
1
1
1
2
2
2
2
3
3
3
3
2
3
3
3
3
3
3
Profit Before Tax
46
80
22
14
14
12
10
-10
7
8
10
6
11
13
11
19
17
19
22
32
34
Tax
11
21
6
4
4
2
3
-2
2
2
2
2
3
4
3
5
5
4
6
6
8
Net Profit
34
60
16
11
11
9
7
-7
5
6
8
4
8
9
9
15
12
14
16
25
26
EPS in ₹
32.96
57.33
15.20
9.97
9.99
8.82
6.82
-7.23
5.10
5.99
7.39
4.08
8.04
8.15
8.21
13.95
11.49
13.60
15.42
24.39
24.69

Balance Sheet

Balance Sheet
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
Total Assets
37
51
71
96
105
133
166
341
354
394
447
592
Fixed Assets
13
13
17
20
29
43
57
92
121
139
146
156
Current Assets
25
38
53
75
75
89
106
228
207
243
284
406
Capital Work in Progress
0
0
0
0
0
0
3
12
14
0
0
17
Investments
1
2
3
5
4
3
4
0
0
0
0
0
Other Assets
24
37
51
71
72
87
102
237
219
255
302
420
Total Equity & Liabilities
37
51
71
96
105
133
166
341
354
394
447
592
Current Liabilities
17
27
42
62
61
68
78
140
126
152
170
226
Non Current Liabilities
1
3
4
6
8
20
28
21
29
20
15
37
Total Equity
19
21
25
29
36
45
60
180
199
223
262
330
Reserve & Surplus
15
17
20
19
27
36
51
171
190
214
254
321
Share Capital
4
5
5
10
10
10
10
10
10
10
10
10

Cash Flow

Cash Flow
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
Net Cash Flow
1
0
2
-1
-0
0
4
3
-6
-1
10
-11
Investing Activities
-1
-3
-7
-6
-12
-18
-23
-63
-48
-26
-29
-35
Operating Activities
1
-3
4
-1
14
6
27
61
41
43
53
17
Financing Activities
1
6
5
5
-2
12
1
6
1
-17
-14
7

Share Holding

% Holding
Mar 2021
Sept 2021
Dec 2021
Mar 2022
Jun 2022
Sept 2022
Dec 2022
Mar 2023
Jun 2023
Sept 2023
Dec 2023
Mar 2024
Jun 2024
Sept 2024
Dec 2024
Mar 2025
Jun 2025
Sept 2025
Dec 2025
Mar 2026
Jun 2026
Promoter
54.13 %
54.24 %
54.24 %
54.43 %
54.45 %
54.45 %
54.45 %
54.74 %
54.74 %
54.77 %
54.77 %
54.83 %
54.83 %
54.83 %
54.83 %
54.83 %
54.83 %
54.83 %
54.83 %
54.87 %
54.86 %
FIIs
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.50 %
2.79 %
3.13 %
DIIs
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.01 %
0.01 %
0.01 %
0.01 %
0.01 %
0.00 %
0.00 %
0.02 %
0.03 %
0.32 %
0.33 %
0.33 %
0.33 %
0.36 %
0.56 %
Government
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
Public / Retail
23.18 %
25.38 %
25.91 %
26.29 %
26.54 %
26.25 %
25.92 %
26.27 %
29.29 %
31.64 %
32.95 %
31.70 %
31.78 %
32.78 %
33.25 %
33.39 %
33.32 %
33.68 %
33.02 %
31.64 %
31.03 %
Others
22.69 %
20.38 %
19.84 %
19.28 %
19.01 %
19.30 %
19.63 %
18.99 %
15.96 %
13.58 %
12.27 %
13.47 %
13.40 %
12.38 %
11.90 %
11.47 %
11.52 %
11.16 %
11.32 %
10.35 %
10.42 %
No of Share Holders
148
168
379
581
1,049
4,198
5,376
6,211
6,943
6,291
5,786
5,695
5,273
7,487
8,947
9,420
10,115
11,595
10,709
10,555
13,279

Dividend History

Annual Cash Flows 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026
Dividend Per Share (₹) 0.6 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Dividend Yield (%) 1.46 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00

Corporate Action

Record Date Corporate Action Information Announcement Day LTP at Annoucement LTP at Record Day
31 Aug 2026 ANNUAL GENERAL MEETING Annual General Meeting
NA
31 Aug 2026 2,611.80 3,318.75
12 Oct 2017 BONUS Bonus
1:1
11 Oct 2017 0.00 0.00
24 Sept 2024 ANNUAL GENERAL MEETING Annual General Meeting
NA
24 Sept 2024 783.50 808.10
30 Oct 2024 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
30 Oct 2024 818.30 812.35
31 Jan 2025 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
31 Jan 2025 892.20 870.20
19 May 2025 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
19 May 2025 719.45 809.00
11 Aug 2025 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
11 Aug 2025 1,124.45 1,132.65
09 Sept 2025 ANNUAL GENERAL MEETING Annual General Meeting
NA
09 Sept 2025 1,069.05 946.35
13 Nov 2025 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
13 Nov 2025 898.20 881.15
12 Feb 2026 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
12 Feb 2026 1,058.00 1,147.50
19 May 2026 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
19 May 2026 1,727.00 1,833.80
10 Aug 2026 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
10 Aug 2026 2,586.00 2,611.80

Announcements

Announcement under Regulation 30 (LODR)-Newspaper Publication11 hrs ago
Announcement under Regulation 30 (LODR)-Newspaper Publication1 day ago
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome1 day ago
Announcement under Regulation 30 (LODR)-Earnings Call Transcript1 day ago
Announcement under Regulation 30 (LODR)-Earnings Call Transcript1 day ago
Announcement under Regulation 30 (LODR)-Investor Presentation3 days ago
Submission Of Standalone And Consolidated Unaudited Financial Results For The Quarter Ended On 30.06.2026 Under Regulation 33 Of The SEBI (LODR) Regulations 20153 days ago
Board Meeting Outcome for Submission Of Standalone And Consolidated Unaudited Financial Results For The Quarter Ended On 30.06.2026 Under Regulation 33 Of The SEBI (LODR) Regulations 20153 days ago
Notice Convening The 43Rd Annual General Meeting ("AGM") Of The Company On Monday 31St August 2026 At 12 :00 Noon. (IST) Through Video Conferencing (VC) / Other Audio Visual Means (OA VM).4 days ago
Reg. 34 (1) Annual Report.4 days ago
Intimation Of Book Closure5 days ago
Intimation Of 43Rd Annual General Meeting5 days ago
Board Meeting Outcome for Board Meeting Outcome For Intimation Of AGM5 days ago
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation9 days ago
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation9 days ago
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation9 days ago
Board Meeting Intimation for Consideration And Approval Of Standalone & Consolidated Unaudited Financial Results For The Quarter Ended 30-06-2026.10 days ago
Disclosure Under Regulation 30 Of SEBI LODRJul 24, 2026
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Jul 13, 2026
Closure of Trading WindowJun 29, 2026
Announcement under Regulation 30 (LODR)-Resignation of DirectorJun 02, 2026
Announcement under Regulation 30 (LODR)-Change in ManagementJun 02, 2026
Compliances-Reg.24(A)-Annual Secretarial ComplianceMay 30, 2026
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - OutcomeMay 28, 2026
Announcement under Regulation 30 (LODR)-Newspaper PublicationMay 22, 2026
Announcement under Regulation 30 (LODR)-Earnings Call TranscriptMay 21, 2026
Announcement under Regulation 30 (LODR)-Investor PresentationMay 19, 2026
Audited Financial Results For The Quarter And Year Ended 31St March 2026.May 19, 2026
Board Meeting Outcome for Audited Financial Results For The Quarter And Year Ended 31St March 2026May 19, 2026
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationMay 14, 2026
Board Meeting Intimation for Considering The Standalone & Consolidated Audited Financial Results For The Quarter And Year Ended March 31 2026May 08, 2026
Announcement under Regulation 30 (LODR)-Credit RatingMay 08, 2026
Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure AApr 30, 2026
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Apr 08, 2026
Shareholder Meeting / Postal Ballot-Outcome of Postal_BallotMar 30, 2026
Shareholder Meeting / Postal Ballot-Scrutinizer"s ReportMar 30, 2026
Closure of Trading WindowMar 26, 2026
Update On Bioequivalence (BE) Program - Successful Completion Of Phase 1 By Kwality Pharmaceuticals Ltd.Mar 10, 2026
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationMar 05, 2026
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationMar 05, 2026
Announcement under Regulation 30 (LODR)-Newspaper PublicationFeb 27, 2026
Shareholder Meeting / Postal Ballot-Notice of Postal BallotFeb 26, 2026
Announcement under Regulation 30 (LODR)-Newspaper PublicationFeb 20, 2026
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - OutcomeFeb 14, 2026
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - OutcomeFeb 14, 2026
Investor Presentation Of Financial Results For The Quarter And Nine Months Ended December 31 2025Feb 12, 2026
Approval Of Unaudited Financial Results For The Quarter And Nine Months Ended 31-12-2025Feb 12, 2026
Board Meeting Outcome for Approval Of Unaudited Financial Results For The Quarter And Nine Months Ended December 31 2025Feb 12, 2026
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationFeb 05, 2026
Announcement under Regulation 30 (LODR)-Change in ManagementFeb 04, 2026

Mutual Fund Holdings

Funding HouseCurrent Holding %1M Change1M Change %3M Change %Last 6M Trend
Bandhan BSE Healthcare Index Fund Direct-Growth
0.07%
0
0.00%
-0.01%

Technical Indicators

RSI(14)
Neutral
75.32
ATR(14)
Less Volatile
173.93
STOCH(9,6)
Neutral
64.54
STOCH RSI(14)
Overbought
100.00
MACD(12,26)
Bullish
66.66
ADX(14)
Strong Trend
26.89
UO(9)
Bearish
68.50
ROC(12)
Uptrend And Accelerating
22.37
WillR(14)
Overbought
-14.19